Platelet Activation Markers in Pediatric Cardiac Surgery

Completed

Conditions studied: Coronary Disease

In brief

In this study the focus will be on correlating the levels of platelet activation markers (proteins that are released when blood cells are activated)to the duration of cardiopulmonary bypass, temperature during cardiopulmonary bypass and the weight of the patient.

Key facts

Study ID

NCT00450151

Run by

Weill Medical College of Cornell University

People needed

10

Starts

2007-02-01

Expected to finish

2009-02-01

Last updated by the study team

2012-03-01

Who can join

Age: any, up to 7. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients scheduled to have surgery involving cardiopulmonary bypass for congenital cardiac abnormalities.
• Age: Newborn to 7 years
• Gender: male and female

You may not qualify if…

• Emergency surgery
• Weight less than 3 kg
• Age greater than 7 years
• Patients with low platelet counts (<100,000)
• Patients on medications that are known to interfere with platelet function such as prostacyclins, non-steroidal anti-inflammatory drugs, plavix.
• Patients whose parents not willing to give consent

Where it is running

• NewYork-Presbyterian Hospital-Weill Cornell Medical College — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.